Global Pharmaceutical Excipients Marketembed
Pharmaceutical excipients are crucial contents of a formulation that enable effective drug absorption.
Pharmaceutical Excipients Market - Trends, Analysis and Forecast till 2024, GE Healthcare Pharmaceutical excipients are crucial contents of a formulation that enable effective drug absorption. Excipients must suit the intended dosage form and comply with regulatory requirements i.e. pharmacopeial standards to ensure finished product quality. Moreover, their compatibility is crucial in dosage forms that involves taste masking, coating, controlled and sustained release, and oil base (emulsifiers). The International Pharmaceutical Excipient Councils (IPE) governs the global pharmaceutical excipient manufacturing by providing harmonized excipient guidelines to manufacturers. For In depth Information Get Sample Copy of this Report @ https://bit.ly/2Uhdpod Excipients used in drug manufacturing serve as binders, diluents, glidents, or disintegrants. Thus, multifunctional excipients can lower the drug development and manufacturing cost of the product. Generics market has witnessed robust growth in recent times, owing to patent expiries, in turn acting as a major factor driving demand for pharmaceutical excipients. Moreover, meeting growing demand for pharmaceutical products and large patient population base would propel growth of pharmaceutical excipients market. However, stringent regulations, especially inspection of manufacturing sites by the regulatory authorities such as the FDA, MHRA and TGA has impacted the supply of pharmaceutical excipients globally. China and India are the major suppliers of pharmaceutical excipients outside the U.S. and European markets. China is the largest supplier of low cost API and excipients. Demand for high-quality and functional excipients is high in developed markets, while emerging economies tend to prefer low cost alternatives. The global pharmaceutical excipients market was valued at US$ 5,394.2 million in 2015 and is expected to witness a robust CAGR of 6.9% during the forecast period (2016 – 2024). Market Dynamics Demand for high-quality excipients is more in developed economies, while affordability is the key criteria considered for price sensitive emerging economies. China has emerged as the largest supplier of low-cost pharmaceutical API and excipients. India is the other fast emerging market to which production of excipients is outsourced owing to lower labor and production costs. North America and Europe lead the market for excipients as the number of excipient manufacturers are high in these regions. Moreover, high cost of manufactured excipients generates higher revenue for these regions compared to cost of material produced by manufacturers in Asia Pacific. However, growing pharmaceutical drug price pressure across the globe is expected to drive growth of the markets in China and India characterized by high supply of low cost excipients. Report includes chapters which deeply display the following deliverable about industry : • Global Pharmaceutical Excipients Market Research Objective and Assumption • Global Pharmaceutical Excipients Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Global Pharmaceutical Excipients Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Global Pharmaceutical Excipients Market, By Regions • Global Pharmaceutical Excipients Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Global Pharmaceutical Excipients Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Global Pharmaceutical Excipients Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Global Pharmaceutical Excipients Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Market Taxonomy This report segments the global pharmaceutical excipients market on the basis of chemistry, functionality, application, and geography. On the basis of chemistry, the market is categorized into plants, animals, minerals and synthetic sources. On the basis of functionality, the market is segmented into binders, diluents, glidents, disintegrants, and others. The application segment is divided into oral, parenteral, topical and others. For comprehensive understanding of market dynamics, the global pharmaceutical excipients market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market. Oral and topical segment is driving the pharmaceutical excipients market growth Excipients are largely used in the production of oral dosage forms such as tablets, capsules, and liquids when compared to parenteral dosage forms. The growth of excipients usage in oral dosage forms is expected to be 7.2% over the forecast period. Local players entering the pharmaceutical industry mark their entry with oral dosage forms, as manufacturing of these are easier when compared to other dosage forms. Economies such as India, Brazil, China, and U.S. are few major pharmaceutical excipients markets, as they have large presence of regional pharmaceutical players. Therefore, demand for excipients is expected to be high in such economies. Moreover, growing topical solutions (cream, gel, eye drops, skin patch) in dermatology and pain management categories is also expected to increase the demand for excipients, thereby driving growth of the market. Request For Customization of Research Report @ https://bit.ly/2NG2YbB Key companies covered as a part of this study include BASF SE, The DOW Chemical Company, Evonik Industries, FMC Corporation, Croda International PLC, Ashland Inc., Roquette Group, Lubrizol Corporation, Innophos Holdings Inc. and MEGGLE Group Wasserburg BG Excipients & Technology Also, Coherent Market Insights has a proprietary database of pipeline biologics and biosimilars, called PHASE-XS. This database provides analytical data in addition to the clinical information of ongoing trials for biologics and biosimilars. An amalgamation of more than 30 parameters, PHASE-XS helps biotechnology and pharmaceutical companies to analyze the market trend, competition, and market potential. For more information or to access this database, kindly click on the below link or contact at [email protected] https://www.coherentmarketinsights.com/phase-xs/ About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected]